1. Home
  2. NVCR vs CPA Comparison

NVCR vs CPA Comparison

Compare NVCR & CPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • CPA
  • Stock Information
  • Founded
  • NVCR 2000
  • CPA 1947
  • Country
  • NVCR Jersey
  • CPA Panama
  • Employees
  • NVCR N/A
  • CPA N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • CPA Air Freight/Delivery Services
  • Sector
  • NVCR Health Care
  • CPA Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • CPA Nasdaq
  • Market Cap
  • NVCR 3.0B
  • CPA 3.6B
  • IPO Year
  • NVCR 2015
  • CPA 2005
  • Fundamental
  • Price
  • NVCR $30.97
  • CPA $87.79
  • Analyst Decision
  • NVCR Buy
  • CPA Strong Buy
  • Analyst Count
  • NVCR 5
  • CPA 6
  • Target Price
  • NVCR $33.40
  • CPA $152.17
  • AVG Volume (30 Days)
  • NVCR 1.9M
  • CPA 388.7K
  • Earning Date
  • NVCR 10-30-2024
  • CPA 02-05-2025
  • Dividend Yield
  • NVCR N/A
  • CPA 7.31%
  • EPS Growth
  • NVCR N/A
  • CPA 62.61
  • EPS
  • NVCR N/A
  • CPA 15.07
  • Revenue
  • NVCR $577,738,000.00
  • CPA $3,480,417,000.00
  • Revenue This Year
  • NVCR $19.13
  • CPA $0.98
  • Revenue Next Year
  • NVCR $5.38
  • CPA $7.33
  • P/E Ratio
  • NVCR N/A
  • CPA $5.90
  • Revenue Growth
  • NVCR 14.63
  • CPA 1.33
  • 52 Week Low
  • NVCR $11.70
  • CPA $80.01
  • 52 Week High
  • NVCR $34.13
  • CPA $114.00
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 60.66
  • CPA 41.64
  • Support Level
  • NVCR $29.85
  • CPA $86.39
  • Resistance Level
  • NVCR $34.13
  • CPA $90.26
  • Average True Range (ATR)
  • NVCR 2.00
  • CPA 2.49
  • MACD
  • NVCR -0.33
  • CPA 0.20
  • Stochastic Oscillator
  • NVCR 44.92
  • CPA 39.76

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About CPA Copa Holdings S.A.

Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama and domestic and international air transportation for passengers, cargo and mail with a point-to-point route network through Copa Colombia a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.

Share on Social Networks: